SCHEMBL21260141

SCHEMBL21260141

N#Cc1c[nH]nc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756852 0.71
SCHEMBL16660378 0.71
SCHEMBL3358649 0.71
SCHEMBL29118313 0.71
SCHEMBL16297134 0.71
SCHEMBL11355831 0.71
SCHEMBL22004673 0.70 ERBB2 (0.53)
Hydrochloric Acid SCHEMBL4850505 0.70
SCHEMBL20623620 0.69
SCHEMBL6843422 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12358878-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2025-07-15 US disclosed
EP-3858811-B1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2024-07-17 EP disclosed
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2023-11-30 US disclosed
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2023-11-30 US disclosed
US-20230382870-A1 N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECH CO LTD (CN) 2023-11-30 US disclosed
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-09-19 US disclosed
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-09-19 US disclosed
US-11760727-B2 N-aromatic amide compounds, preparation methods and uses thereof SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-09-19 US disclosed
US-11661437-B2 Steroid derivative regulators, method for preparing the same, and uses thereof JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-05-30 US disclosed
US-11661437-B2 Steroid derivative regulators, method for preparing the same, and uses thereof JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-05-30 US disclosed
US-20210214311-A1 N-AROMATIC AMIDE COMPUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2021-07-15 US disclosed
US-20210214311-A1 N-AROMATIC AMIDE COMPUNDS, PREPARATION METHODS AND USES THEREOF SHENZHEN EDK PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2021-07-15 US disclosed
US-20210139530-A1 STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2021-05-13 US disclosed
WO-2021023213-A1 SALT AND CRYSTAL FORM OF STEROID DERIVATIVE REGULATOR 上海翰森生物医药科技有限公司 2021-02-11 WO disclosed
EP-3750908-A1 STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2020-12-16 EP disclosed
EP-3750909-A1 STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2020-12-16 EP disclosed
CN-110963957-A N-aromatic amide compound and preparation method and application thereof 深圳恩多凯医药科技有限公司 2020-04-07 CN disclosed
WO-2020063407-A1 N-AROMATIC AMIDES COMPOUND AND PREPARATION METHOD AND USE THEREOF 深圳恩多凯医药科技有限公司 2020-04-02 WO disclosed
WO-2019154247-A1 STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF 江苏豪森药业集团有限公司 2019-08-15 WO disclosed
WO-2019154257-A1 STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF 江苏豪森药业集团有限公司 2019-08-15 WO disclosed